H-2-driven biotransformation of n-octane to 1-octanol by a recombinant Pseudomonas putida strain co-synthesizing an O-2-tolerant hydrogenase and a P450 monooxygenase by Lonsdale, Thomas H. et al.
As featured in:
See Lars Lauterbach, 
Oliver Lenz et al.,
Chem. Commun., 2015, 51, 16173.




-driven biotransformation of n-octane to 1-octanol by a 
recombinant Pseudomonas putida strain co-synthesizing an 
O
2
-tolerant hydrogenase and a P450 monooxygenase 
A recombinant bacterial whole-cell system was designed for 
hydroxylation of n-octane to 1-octanol. An intracellular 
NAD+-reducing hydrogenase sustains H
2
-driven regeneration 
of NADH even in the presence of O
2
, both are co-substrates of 
the CYP153A monooxygenase.
Registered charity number: 207890
www.rsc.org/chemcomm
This journal is©The Royal Society of Chemistry 2015 Chem. Commun., 2015, 51, 16173--16175 | 16173
Cite this:Chem. Commun., 2015,
51, 16173
H2-driven biotransformation of n-octane to
1-octanol by a recombinant Pseudomonas putida
strain co-synthesizing an O2-tolerant hydrogenase
and a P450 monooxygenase†
Thomas H. Lonsdale,‡ab Lars Lauterbach,‡*a Sumire Honda Malca,c
Bettina M. Nestl,c Bernhard Hauerc and Oliver Lenz*a
An in vivo biotransformation system is presented that aﬀords the
hydroxylation of n-octane to 1-octanol on the basis of NADH-
dependent CYP153A monooxygenase and NAD+-reducing hydro-
genase heterologously synthesized in a bacterial host. The
hydrogenase sustains H2-driven NADH cofactor regeneration even
in the presence of O2, the co-substrate of monooxygenase.
Cytochrome P450 monooxygenases (CYPs) have the extraordinary
capability to introduce oxygen into non-activated C–H bonds in
a regio- and stereoselective manner, which is still a challenging
task for synthetic catalysts. The continuous discovery of novel
CYPs and their modification by protein engineering paves new
avenues for their utilization as biocatalysts in the production of
pharmaceuticals and fine chemicals.1–3
In particular the regioselective terminal hydroxylation of
alkanes by CYPs is of significant interest because the corres-
ponding alkanols can be used as surfactants, plasticizers,
solvents or polymer precursors.4 In this study we used the tri-
partite alkane-oxidizing CYP153A system from Polaromonas
sp. JS666 for selective oxidation of n-octane to 1-octanol.5 The
system is composed of the catalytically active cytochrome
(CYP153A), the electron carrier ferredoxin (Fd) and the FAD-
containing ferredoxin reductase (FRN). The latter two proteins
are necessary for electron transfer from NADH to the P450 active
site (Fig. 1, see ESI,† for details). CYP153 enzymes are promising
biocatalysts as they can be heterologously produced in active and
soluble form.4 For eﬃcient use of CYPs both in vitro and in vivo,
a suﬃcient supply of the reduced cofactor NADH is required. In
whole-cell systems, NAD(P)H is generated either from the basic
metabolic routes or via a recombinant regeneration system,
generally based on glucose dehydrogenase relying on the sup-
plementation of the growth medium with glucose.6 Whole-cell
catalysis for chemical synthesis is attractive because enzymes are
generally more stable in their natural environment. Recently, a
hydrogenase that oxidizes dihydrogen (H2) and transfers the
released electrons to NAD+ has complemented the so-far esta-
blished systems for NADH regeneration.7–10 In contrast to glucose,
H2 readily diffuses through cell membranes, and hydrogenase-
based NADH recycling has the advantage of proceeding without a
carbon-based reducing agent. Moreover, when coupled with CYP-
mediated catalysis water is the only by-product (Fig. 1).11
Exposure of most hydrogenases to O2 leads to their irreversible
inactivation.12 However, a few O2-tolerant [NiFe]-hydrogenases
sustain catalytic activity in the presence of O2. One of the most
prominent examples is the NAD+-reducing hydrogenase (SH) from
the ‘‘Knallgas’’ bacterium Ralstonia eutropha H16 consisting
of two functionally distinct heterodimeric moieties.13 The
H2-dependent NAD
+ reduction activity of the SH is unaﬀected
even at ambient O2 concentrations.
14 These features make the
SH particularly promising for NADH regeneration in cascade
reactions requiring O2, e.g. those involving CYPs.
Fig. 1 H2-driven conversion of n-octane to 1-octanol in recombinant
Pseudomonas putida KT2440 cells producing the soluble NAD+-reducing
hydrogenase (SH) from Ralstonia eutropha in addition to CYP153A (CYP),
NADH-ferredoxin reductase (FRN), and ferredoxin (Fd) from Polaromonas
sp. JS666. The SH contains two flavin mononucleotide (FMN)molecules, and
FRN contains one flavin adenine dinucleotide (FAD). Electron-conducting
iron–sulfur clusters are shown as cluster-forming spheres coloured in
brown and yellow.
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In this study, we have designed an electron transfer pathway
for the H2-driven o-hydroxylation of n-octane to 1-octanol in
recombinant Pseudomonas putida.§ Pseudomonads provide an
attractive platform for new metabolic pathways due to their
solvent resistance, metabolic versatility and simple genetic
accessibility.15 Biosynthesis of the [NiFe] active site of the SH is
highly complex and requires a set of auxiliary proteins involved in
nickel uptake, metal centre assembly and insertion, site-specific
endoproteolysis and transcriptional regulation.16 The corres-
ponding set of 13 genes is arranged as an operon and was set
under control of the alkB promoter that controls alkane degrada-
tion in Pseudomonas putida GPo1.17 The three genes required for
biosynthesis of the CYP153A system from Polaromonas sp. JS666
were likewise equipped with the alkB promoter. Both recombi-
nant operons were inserted into a broad-host-plasmid replicating
in P. putida KT2440 (see footnote § and ESI,† for details). In order
to obtain the optimal growth conditions for the biotransforma-
tions, both the SH activity and the CYP concentration were
determined dependent on the length of the induction period.
Recombinant P. putida cells were first grown for 12 hours in a
glucose–glycerol (GGN) minimal medium.
Gene expression was induced through addition of dicyclo-
propyl ketone (DCPK), which cannot be metabolized by P. putida.
In the course of the induction period (24 h), the CYP concen-
tration showed an almost continuous increase reaching a final
value of 0.58 nmol mg1 (of total protein) after 24 h (Table S1,
ESI†). The SH activity, by contrast, showed a considerable
increase during the first 4 h of induction and then stayed
relatively stable at 0.15 U mg1 for a further 4 h. However, less
than 50% of the maximal activity was left after 24 h (Table S1,
ESI†). Henceforth, all subsequent biotransformations were carried
out with resting cells derived from a recombinant P. putida culture
grown for 12 hours in GGN minimal medium followed by an
induction period of 6 h.
After induction the cells were centrifuged, and the cell pellet
was re-suspended in carbon-free H16 minimal medium con-
taining n-octane. Biotransformations with 15% (v/v) n-octane
were performed in gas-tight reaction vessels containing a gas
mixture of H2 and air in the headspace. The same setup without
H2 was used to evaluate the biotransformation capacity of the
system without support of the SH.
The addition of H2 led to a significantly higher yield of
1-octanol (Fig. 2), demonstrating the supportive role of SH-
generated NADH during the biotransformation. After 24 h,
101 mg L1 and 36 mg L1 of 1-octanol were formed in the
presence and absence of H2, respectively. The maximum concen-
tration of 1-octanol in the biotransformation mixture was approxi-
mately five times higher than that achieved previously in in vitro
experiments with purified Polaromonas sp. JS666 CYP153A.5
Further oxidation products such as octanoic acid and
2-octanol/octanal were found to constitute 39% of the total
octane oxidation products (Table 1). Overoxidation is frequently
observed in biotransformations involving P450 enzymes, and in
a previous in vitro study, up to 10% of the octane was shown to
be overoxidized by CYP153A.5 In contrast to the latter study,
however, no a,o-diols were detected in our in vivo approach.
From these observations, it seems likely that the accumulation
of octanoic acid and 2-octanol/octanal resulted from a combi-
nation of direct overoxidation by CYP153A and native catabolic
pathways for 1-octanol degradation present in P. putida. Indeed,
in contrast to wild-type P. putida KT2440, the recombinant
strain synthesizing the CYP153A system was able to grow with
n-octane as the sole carbon and energy source (Fig. S2, ESI†).
This clearly indicates catabolic degradation of 1-octanol in vivo.
Future mutagenesis studies18 are envisaged to identify potential
alcohol dehydrogenases involved in 1-octanol conversion.
A subsequent knock-out of the corresponding gene(s) is expected
to reduce the amount of overoxidation products.
Recombinant P. putida KT2440 cells synthesizing both the
CYP153A system and SH grew even slightly faster when H2 was
added (Fig. S3, ESI†). This result in combination with the increased
1-octanol production in the presence of H2 point out that NADH-
regeneration in carbon-free minimal medium is significantly facili-
tated by the SH. This is in marked contrast to the results obtained
for cells grown in glucose-supplemented mineral medium,
where P. putida is able to adjust its energy and reductant demand
according to the metabolic burden.15,19
In our proof-of-concept study, we investigated the applicability
of the R. eutropha SH to increase the NADH supply in whole cell
systems. H2-supported NADH recycling led to an approximately
Fig. 2 H2-supported production of 1-octanol by recombinant P. putida
KT2440 cells synthesizing CYP153A and SH. Bioconversions were moni-
tored either in the absence (open bars) or presence (dashed bars) of H2. The
bar height represents the mean value of three replicates, and the corres-
ponding standard deviation is indicated.
Table 1 H2-supported conversion of n-octane to 1-octanol, octanoic
acid and 2-octanol/octanal. The measurement replicates were done in
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3-fold increase in the 1-octanol yield in a whole-cell biotrans-
formation system, which uses a dedicated P450 monooxygenase
as octane-converting biocatalyst. In order to prevent formation
of hazardous gas mixtures during in vivo biotransformation, the
application of sub-critical gas concentrations, such aso8 vol%
O2 and o5 vol% H2, is recommended.20,21 Our study clearly
shows that the SH is capable of overcoming potential bottlenecks
of cofactor supply in whole-cell systems. Moreover, H2 represents
a viable alternative to carbon-based reductants currently used for
in vivo cofactor recycling strategies. Thus, our H2-driven in vivo
cofactor regeneration system holds considerable potential for
application in other cascades reactions that rely on sustainable
supply of NAD(P)H as the reducing agent.
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§ The heterologous overproduction system for the SH from R. eutropha
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2 L-Erlenmeyer flasks including 300 mL of mineral salts medium14
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energy sources (GGN medium). Inoculation was done with 3 mL of a
starter culture grown previously for 48 h in mineral salts medium with
0.4% (w/v) glucose. Induction of the alkB promoter was carried out by
addition of 0.05% (v/v) dicyclopropyl ketone, and CYP production was
enhanced through addition of 0.5 mM 5-aminolevulinic acid and 1 mM
FeCl2.
5 H2 oxidation activity in soluble extracts was measured spectro-
photometrically at 30 1C by following the conversion of NAD+ into
NADH at 365 nm.14 Protein concentration was determined using the
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were analyzed using GC-FID, see ESI,† for details.
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